EPIZQA Trademark

Trademark Overview


On Wednesday, September 7, 2022, a trademark application was filed for EPIZQA with the United States Patent and Trademark Office. The USPTO has given the EPIZQA trademark a serial number of 79354334. The federal status of this trademark filing is REGISTERED as of Tuesday, October 10, 2023. This trademark is owned by SAMSUNG BIOEPIS CO., LTD.. The EPIZQA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; antidiabetic preparations; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceut...
epizqa

General Information


Serial Number79354334
Word MarkEPIZQA
Filing DateWednesday, September 7, 2022
Status700 - REGISTERED
Status DateTuesday, October 10, 2023
Registration Number7185271
Registration DateTuesday, October 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; antidiabetic preparations; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, November 13, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 13, 2023FINAL DISPOSITION PROCESSED
Thursday, November 9, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, October 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTICE OF PUBLICATION
Thursday, June 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 22, 2023ASSIGNED TO EXAMINER
Tuesday, November 22, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, November 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 14, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 3, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB